BioSig Technologies, Inc. STEX Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s deferred tax assets?
- BioSig Technologies, Inc. (STEX) reported deferred tax assets of -$565K in Q1 2026.
- What is the long-term trend for BioSig Technologies, Inc.'s deferred tax assets?
- Over 4 years (2020 to 2024), BioSig Technologies, Inc.'s deferred tax assets has grown at a -52.1% compound annual growth rate (CAGR), from $4.8M to $252K.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.